JAVIER
ZAMORA ROMERO
Investigador en el periodo 2009-2010
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (5)
2021
-
Prognostic models for mortality after cardiac surgery in patients with infective endocarditis: a systematic review and aggregation of prediction models
Clinical Microbiology and Infection, Vol. 27, Núm. 10, pp. 1422-1430
2020
-
Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial
Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162
2014
-
Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: A double blind prospective study
Journal of Cystic Fibrosis, Vol. 13, Núm. 6, pp. 716-722
2011
-
Influence of nomenclature in the interpretation of lumbar disk contour on MR imaging: A comparison of the agreement using the combined task force and the nordic nomenclatures
American Journal of Neuroradiology, Vol. 32, Núm. 6, pp. 1143-1148
2010
-
Role of Endoscopy in Primary Prophylaxis for Esophageal Variceal Bleeding
Clinics in Liver Disease, Vol. 14, Núm. 2, pp. 231-250